Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XLV
XLV logo

XLV Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
145.205
Open
144.555
VWAP
144.75
Vol
10.89M
Mkt Cap
--
Low
144.320
Amount
1.58B
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

(ET)
2025-11-28
08:23:48
Health Care Select Sector SPDR: Key Turning Points
select
2025-11-24 (ET)
2025-11-24
08:24:14
Health Care Select Sector SPDR: Key Turning Points
select
2025-11-17 (ET)
2025-11-17
08:24:05
Health Care Select Sector SPDR: Key Turning Points
select
2025-11-14 (ET)
2025-11-14
08:23:40
Health Care Select Sector SPDR: Key Turning Points
select

News

stocktwits
8.0
04-07stocktwits
UNH vs. HUM: Which Insurance Stock Offers Greater Potential Following CMS's Reversal of Wall Street's Major Medicare Rate Concern?
  • Medicare Advantage Funding Increase: A revised policy is set to add over $13 billion in funding to Medicare Advantage plans, following a previous proposal that significantly impacted insurers' market value.

  • Stock Performance: Shares of UnitedHealth (UNH) rose by 8% and Humana (HUM) gained 11% after the announcement, although both stocks have seen declines of approximately 45% and 27% respectively over the past year.

  • Payment Rate Adjustments: The Centers for Medicare & Medicaid Services (CMS) finalized a 2.48% increase in Medicare Advantage payment rates for 2027, reversing earlier proposals that kept rates flat.

  • Market Sentiment: Retail sentiment for UNH and HUM remains bullish, with analysts providing a range of ratings, indicating a strong outlook for UnitedHealth's expanding AI strategy and potential revenue relief amidst rising medical costs.

Barron's
6.5
03-30Barron's
Pharma Stocks Pfizer and GSK Provide Safe Investment Options Amid Market Uncertainty: Charts
  • Pharmaceutical Stocks in Focus: Investors are increasingly interested in pharmaceutical stocks as a stable investment option amid market uncertainty.

  • Market Volatility Impact: The sector is gaining attention due to its steady demand and resilient earnings, which are less affected by economic fluctuations.

Marketbeat
3.0
03-24Marketbeat
Implications of Q1 Earnings for the S&P 500's Upward Trend
  • Q1 2026 Earnings Outlook: The upcoming Q1 2026 earnings season is expected to show positive growth for the S&P 500, with earnings growth projected at 12.5%, driven by strong forecasts and a favorable market outlook.

  • Sector Performance Expectations: The Information Technology sector is anticipated to lead growth with nearly 45% growth, while the Materials and Financials sectors are also expected to perform well, although the Health Care sector faces risks due to various challenges.

  • Market Volatility and Risks: Investors should prepare for increased volatility in the market, particularly with NVIDIA and other major stocks influencing market movements, while oil prices pose a risk to earnings across sectors.

  • Guidance and Future Trends: Guidance from earnings results will be crucial for sustaining market momentum, with expectations for accelerated growth in Q2 and a focus on maintaining high earnings throughout the year.

Barron's
6.5
02-26Barron's
Investors Should Adopt a Defensive Strategy: Offload Staples and Invest in Healthcare.
  • Investment Strategy: Investors are encouraged to shift their focus towards defensive stocks for better stability in uncertain markets.
  • Sector Shift: The recommended approach is to sell off consumer staples and invest in the healthcare sector.
Marketbeat
6.5
02-09Marketbeat
5 Stocks and ETFs to Protect Your Portfolio Amid Market Fluctuations
  • Market Volatility: The U.S. stock market has experienced an unstable start to the year, with heightened volatility and investor pressure, particularly affecting sectors like technology and consumer staples.

  • Defensive Investment Strategies: Investors are increasingly seeking defensive strategies, focusing on sectors such as health care and consumer staples, which have historically performed well during market downturns.

  • Top Investment Options: Five stocks and ETFs are highlighted as potential investments for those looking to shield their portfolios from volatility, emphasizing the importance of resilience and income generation.

  • Consumer Staples Resilience: Companies in the consumer staples sector, like Coca-Cola and Johnson & Johnson, are noted for their consistent demand and dividend reliability, making them attractive options for income-focused investors.

Barron's
3.0
01-28Barron's
Pharma Stocks on the Verge of a Breakthrough: Earnings May Propel Them Forward.
  • Pharmaceutical Stocks Performance: Pharmaceutical stocks have recently reached new highs in the market.
  • Earnings Potential: Upcoming earnings reports are expected to further boost the stock prices of pharmaceutical companies.
Wall Street analysts forecast XLV stock price to rise
0 Analyst Rating
Wall Street analysts forecast XLV stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for (XLV) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding XLV

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (XLV) stock price today?

The current price of XLV is 144.73 USD — it has decreased -0.3

What is (XLV)'s business?

What is the price predicton of XLV Stock?

Wall Street analysts forecast XLV stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for XLV is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (XLV)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (XLV)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (XLV). have?

(XLV) has 0 emplpoyees as of May 05 2026.

What is (XLV) market cap?

Today XLV has the market capitalization of 0.00 USD.